CERS Cerus Corp

Price (delayed)

$5.55

Market cap

$981.79M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.28

Enterprise value

$1.03B

Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies ...

Highlights
CERS's revenue is up by 45% year-on-year and by 8% since the previous quarter
The company's gross profit rose by 36% YoY and by 7% QoQ
The quick ratio has declined by 27% year-on-year but it rose by 2% since the previous quarter
CERS's equity is down by 14% year-on-year and by 6% since the previous quarter
Cerus's debt has increased by 7% YoY

Key stats

What are the main financial stats of CERS
Market
Shares outstanding
176.9M
Market cap
$981.79M
Enterprise value
$1.03B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
12.14
Price to sales (P/S)
5.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.95
Earnings
Revenue
$172.97M
EBIT
-$43.57M
EBITDA
-$38.9M
Free cash flow
-$38.23M
Per share
EPS
-$0.28
Free cash flow per share
-$0.22
Book value per share
$0.46
Revenue per share
$0.99
TBVPS
$1.26
Balance sheet
Total assets
$221.91M
Total liabilities
$141.5M
Debt
$88.54M
Equity
$79.41M
Working capital
$106.15M
Liquidity
Debt to equity
1.11
Current ratio
2.59
Quick ratio
2.04
Net debt/EBITDA
-1.24
Margins
EBITDA margin
-22.5%
Gross margin
59.3%
Net margin
-28.4%
Operating margin
-24.5%
Efficiency
Return on assets
-21.8%
Return on equity
-59.9%
Return on invested capital
-24%
Return on capital employed
-28.1%
Return on sales
-25.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CERS stock price

How has the Cerus stock price performed over time
Intraday
1.65%
1 week
19.35%
1 month
14.91%
1 year
-3.14%
YTD
-18.5%
QTD
1.09%

Financial performance

How have Cerus's revenue and profit performed over time
Revenue
$172.97M
Gross profit
$102.52M
Operating income
-$42.34M
Net income
-$49.2M
Gross margin
59.3%
Net margin
-28.4%
Cerus's operating margin has surged by 51% YoY and by 20% QoQ
CERS's revenue is up by 45% year-on-year and by 8% since the previous quarter
Cerus's net margin has increased by 44% YoY and by 17% QoQ
The company's gross profit rose by 36% YoY and by 7% QoQ

Growth

What is Cerus's growth rate over time

Valuation

What is Cerus stock price valuation
P/E
N/A
P/B
12.14
P/S
5.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.95
CERS's EPS is up by 22% year-on-year and by 13% since the previous quarter
CERS's price to book (P/B) is 18% higher than its 5-year quarterly average of 10.3 but 4.4% lower than its last 4 quarters average of 12.7
CERS's equity is down by 14% year-on-year and by 6% since the previous quarter
CERS's revenue is up by 45% year-on-year and by 8% since the previous quarter
The stock's price to sales (P/S) is 36% less than its 5-year quarterly average of 8.8 and 20% less than its last 4 quarters average of 7.0

Efficiency

How efficient is Cerus business performance
CERS's return on sales is up by 47% year-on-year and by 18% since the previous quarter
Cerus's return on assets has increased by 22% YoY and by 10% QoQ
The ROIC has grown by 18% YoY and by 13% from the previous quarter
CERS's return on equity is up by 6% since the previous quarter but it is down by 3.5% year-on-year

Dividends

What is CERS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CERS.

Financial health

How did Cerus financials performed over time
CERS's total assets is 57% greater than its total liabilities
The quick ratio has declined by 27% year-on-year but it rose by 2% since the previous quarter
Cerus's current ratio has decreased by 22% YoY but it has increased by 9% QoQ
Cerus's debt is 11% higher than its equity
Cerus's debt to equity has increased by 25% YoY and by 7% QoQ
CERS's equity is down by 14% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.